DDAH2 Blocking Peptide

Product Type

Proteins
Product Subtype

Blocking Peptides
Research Area

Cell Biology
Tag Conjugate

MYTLHTKRVKAAARQMWTSNLSKVRQSLKNVYHKCKIRHQDSTGYPTVTS
Type1

Synthetic
Form Buffer

Lyophilized powder. Add 100ul of distilled water for a final peptide concentration is 1 mg/ml.
Storage

Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
Applications

WB, IHC
Shipping Info

Blue Ice
Test

You can block the antibody by the specific target amino acid sequence of peptide.
Properties

blocking peptide
Description

Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

Gene target

DDAH2
Gene symbol

DDAH2
Short name

DDAH2 Blocking Peptide
Technique

blocking peptide, Blocking, peptide, blocking peptides, fitzgerald made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. peptides
Alternative name

dimethylarginine dimethylaminohydrolase 2 inhibiting short protein sequence
Alternative technique

control, peptides
Alternative to gene target

dimethylarginine dimethylaminohydrolase 2, DDAH and DDAHII and G6a and HEL-S-277 and NG30, DDAH2 and IDBG-238590 and ENSG00000213722 and 23564, hydrolase activity, Cytoplasm, Ddah2 and IDBG-176274 and ENSMUSG00000007039 and 51793, DDAH2 and IDBG-633979 and ENSBTAG00000013530 and 540386